Travers Smith LLP has advised longstanding client Kester Capital on its investment in Factory-CRO.
The Travers Smith team was led by private equity partner Paul Dolman and also included senior private equity associate Alex Dixon.
Factory-CRO, a leading CRO focused on the medical device market, was founded over 20 years ago by Dr. Dirk Meijer and Dr. Joris Bannenberg. Since then, Factory-CRO has grown to become a leading CRO in the medical device sector. Headquartered in Bilthoven, Netherlands, Factory-CRO conducts trials for its international customer base across the globe.
Dutch law advice to Kester Capital was provided by NautaDutilh.
Travers Smith has also recently advised Kester Capital on the sale of its stakes in Garretts International and Briefing Media.